Literature DB >> 36262583

Covid Induced Telogen Effluvium (CITE): An Insight.

Arun C Inamadar1.   

Abstract

Hair loss is one of the most common post-covid symptoms observed during this severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Pro-inflammatory cytokines, direct viral effect on hair follicles, and microthrombi are thought to be the pathogenic factors considered. Information regarding time of onset and severity is similar to other infection-induced acute telogen effluvium. It is reasonable to think that the evolution and prognosis are similar, and therefore, even without any specific treatment, full recovery of lost hair is expected. Copyright:
© 2022 Indian Dermatology Online Journal.

Entities:  

Keywords:  COVID 19; SARS-CoV-2 infection; hair loss; telogen effluvium

Year:  2022        PMID： 36262583      PMCID： PMC9574152          DOI： 10.4103/idoj.idoj_139_22

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN： 2229-5178


  19 in total

1.  Interleukin-4 induces apoptosis in cultured human follicular keratinocytes, but not in dermal papilla cells.

Authors:  Nathalie Mandt; Christoph C Geilen; Anna Wrobel; Alexandra Gelber; Hartwig Kamp; Constantin E Orfanos; Ulrike Blume-Peytavi
Journal:  Eur J Dermatol       Date:  2002 Sep-Oct       Impact factor: 3.328

2.  Interleukin-1beta is differentially expressed by human dermal papilla cells in response to PKC activation and is a potent inhibitor of human hair follicle growth in organ culture.

Authors:  Y Xiong; C S Harmon
Journal:  J Interferon Cytokine Res       Date:  1997-03       Impact factor: 2.607

3.  COVID-19 cytokine storm: the interplay between inflammation and coagulation.

Authors:  Ricardo J Jose; Ari Manuel
Journal:  Lancet Respir Med       Date:  2020-04-27       Impact factor: 30.700

4.  Telogen effluvium: a sequela of COVID-19.

Authors:  Karolina Mieczkowska; Alana Deutsch; Jenna Borok; Anthony K Guzman; Renee Fruchter; Parth Patel; Olivia Wind; Beth N McLellan; Ranon E Mann; Caroline P Halverstam
Journal:  Int J Dermatol       Date:  2020-11-23       Impact factor: 2.736

5.  Evolving phenotypes of non-hospitalized patients that indicate long COVID.

Authors:  Hossein Estiri; Zachary H Strasser; Gabriel A Brat; Yevgeniy R Semenov; Chirag J Patel; Shawn N Murphy
Journal:  BMC Med       Date:  2021-09-27       Impact factor: 11.150

Review 6.  Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.

Authors:  Kumaragurubaran Karthik; Tuticorin Maragatham Alagesan Senthilkumar; Shanmugasundaram Udhayavel; Gopal Dhinakar Raj
Journal:  Hum Vaccin Immunother       Date:  2020-08-26       Impact factor: 3.452

7.  Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience.

Authors:  Giulio Rizzetto; Federico Diotallevi; Anna Campanati; Giulia Radi; Tommaso Bianchelli; Elisa Molinelli; Sara Mazzanti; Annamaria Offidani
Journal:  Dermatol Ther       Date:  2020-11-23       Impact factor: 3.858

8.  Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms.

Authors:  Alfredo Rossi; Francesca Magri; Alvise Sernicola; Simone Michelini; Gemma Caro; Marta Muscianese; Marco Di Fraia; Camilla Chello; Maria Caterina Fortuna; Teresa Grieco
Journal:  Skin Appendage Disord       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.